ERBB2 and neoplasm: Interestingly, tumours differed not only by their size but also by their appearance, suggesting that the administration of Lapatinib during the resting phase also inhibited tumour angiogenesis (Fig. 6f, right panel), in line with a similar effect of an anti-HER2 antibody when tested in animals39.